#nameCompanyM

Mark Devlin's email & phone

Opt-Out
Scientific Advisor at Amplia Therapeutics Limited
LinkedIn
View Mark Devlin's Email
Up to 10 free lookups. No credit card required.

Found email address for Mark Devlin:

Found phone for Mark Devlin:

Searching for Mark Devlin profiles
0% completed

A different Mark Devlin?

Sign up to search for other Mark Devlin's across our 850M+ professionals database

Location

Greater Melbourne Area, Australia

Work Experience 24 years

Scientific Advisor at Amplia Therapeutics Limited

Jul 2022 - Current

Chief Scientific Officer at Amplia Therapeutics Limited

Sep 2020 - Current

Chief Executive Officer at Aculeus Therapeutics

Sep 2020 - Current

Chief Scientific Advisor at Amplia Therapeutics Limited

Jan 2017 - Sep 2020

Chief Executive Officer at Oncology One Pty Ltd

Oct 2019 - Aug 2020

Chief Operating Officer at CTx CRC Limited (Cancer Therapeutics CRC)

Jun 2018 - Sep 2019

Associate Professor: Division of Cancer Research at Peter MacCallum Cancer Centre

Jan 2018 - Sep 2019

Senior Research Fellow: Division of Cancer Research at Peter MacCallum Cancer Centre

Jan 2014 - Jan 2018

Senior Research Officer: Division of Cancer Research at Peter MacCallum Cancer Centre

Jan 2008 - Jan 2014

Head of Cancer Therapeutics CRC Translation Cancer Biology Laboratory (Research Division) at Peter MacCallum Cancer Centre

Jan 2008 - Jan 2014

Director: Translation Biology at CTx CRC Limited (Cancer Therapeutics CRC)

Jan 2014 - Jan 2018

Company Director & Secretary at Ocean Pharmaceuticals Pty Ltd

Jan 2005 - Jan 2010

Research Officer: Department of Pharmacology at University of Melbourne

Jan 2006 - Jan 2007

Senior Scientist at Pargenex Pharmaceuticals

Jan 2002 - Jan 2004

Mark Devlin started working in 2002, then the employee has changed 7 companies and 12 jobs. On average, Mark Devlin works for one company for 3 years 7 months.

Education

Master of Business Administration - MBA at Melbourne Business School

Post Graduate Diploma at UNSW

Doctor of Philosophy - PhD at University of Melbourne

Bachelor of Science (Honours) at University of Melbourne

University of Melbourne

Frequently Asked Questions

What is Mark Devlin's minimum period of employment in the companies?

Mark Devlin's minimum period of employment in various companies is 10 months.

What is Mark Devlin's average duration of employment for different companies?

On average, Mark Devlin works for one company for 3 years 3 months

What industries has Mark Devlin worked in?

Mark Devlin works in the Pharmaceuticals. Previously, Mark Devlin worked in the Biotechnology, and Hospital & Health Care, and Higher Education.

What positions has Mark Devlin held before?

Previously, Mark Devlin worked as a Chief Scientific Officer, and Chief Executive Officer, and Chief Scientific Advisor, and Chief Operating Officer, and Associate Professor: Division of Cancer Research.

How do I contact Mark Devlin?

Mark Devlin's email address is m*********n@ampliatx.com, phone number is +61-***-***-5461. Sign up to get contact details.

Who is the President/CEO/Director of the Amplia Therapeutics Limited?

The President/CEO/Director of the Amplia Therapeutics Limited is Chris Burns FAHMS

Who are Mark Devlin's peers at other companies?

Mark Devlin's peers at other companies are Stacey Jones and Abhi Pandey and David Leighton

Mark Devlin Namesakes

Name
Company
Position
M
Deputy Director

Similar profiles

Name
Company
Position
A
Scientific Advisor
D
Carlsbad Aquafarm
Scientific Advisor
M
Scientific Advisor
G
Cystic Fibrosis Foundation Therapeutics
Scientific Advisor
L
Scientific Advisor

Data Privacy

GDPR Icon

GDPR COMPLIANT

SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.

CCPA Icon

CCPA COMPLIANT

SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.

BACK TO TOP